Bli medlem
Bli medlem

Du är här


Actelion Pharmaceuticals Ltd: Actelion statement

Actelion Pharmaceuticals Ltd / Actelion statement. Processed and transmitted
by Nasdaq Corporate Solutions. The issuer is solely responsible for the
content of this announcement.
ALLSCHWIL, SWITZERLAND - 25 November 2016 -
Actelion (SIX: ATLN) confirmed today that it has been approached by
Johnson&Johnson about a possible transaction.

There can be no certainty that a transaction will result.


Press release PDF

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.